CDK12 and ovarian carcinoma: Analysis of data from The Cancer Genome Atlas (TCGA) indicated that the frequency of alterations in the CDK12 (9%) and CDK13 (2.5%) genes was similar (CDK13) or higher (CDK12) with respect to other DDR genes among ovarian cancer patients (n = 398; Fig. 1a).